1.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014806, NCT00766831
|
|
2.
|
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015694, NCT01006356
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18-70
Sponsor: Other
Protocol IDs: CDR0000065866, RPCI-DS-95-35, NCI-G97-1352, NCT00003115
|
|
4.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0961, NCT00542542
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015328, NCT00803283
|
|
6.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017437, 42801PAI3009, NCT01205126
|
|
7.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D3820C00006, 2011-001985-16, NCT01384292
|
|
8.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor:
Protocol IDs: NCI-81-C-203, NCI-MB-168
|
|
9.
|
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8582, NCI-T85-0066D, T85-0066
|
Mobile | Español
